LGALS3 and pulmonary arterial hypertension: The expression of Gal-3 was increased in PAH patients and a hypoxia-induced PAH rat model, and treatment with Gal-3 inhibitor, N-Lac, recovered RVSP, pulmonary artery acceleration, and pulmonary arterial velocity time integral [33].